ArticleMolecular cancer therapeutics2014

Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.

Pei-Li Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.